DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

Biogen Idec (NASDAQ: BIIB)

409.59 -0.51 (-0.12%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $409.59 -0.12%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $410.23
Previous Close $410.10
Daily Range $405.80 - $411.31
52-Week Range $272.02 - $412.02
Market Cap $96.1B
P/E Ratio 33.15
Dividend (Yield) $0.00 (0.0%)
Volume 1,371,021
Average Daily Volume 1,550,605
Current FY EPS $16.79




Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary

Why Don't These Winning Stocks Pay Dividends?

Many big companies could easily pay dividends. Should they?

3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year

These three companies could post better growth than Gilead Sciences that allow them to be top performers this year.

iShares S&P 500 Growth ETF Experiences Big Outflow

Biotech Stock Mailbag: Receptos, Celldex Therapeutics, Exact Sciences

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

5 Things Biogen Idec Inc's Management Wants You to Know

Pipeline data, new drug launches, and sales of established drugs top the list.

The Catalysts Biogen Idec Investors Should Watch

3 Stocks Dragging The Drugs Industry Downward

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

Evercore ISI Technical Analysis: The 'Single Best Idea'

See More BIIB News...

BIIB's Top Competitors

BIIB $409.59 (-0.12%)
Current stock: BIIB
AMGN $157.72 (-0.79%)
Current stock: AMGN
GILD $103.53 (-0.63%)
Current stock: GILD
$0.00 (0.00%)
Current stock: